Business Segments

6 Months Ended

Jun. 30, 2018

9. Business Segments

The Company operates in one segment, ophthalmology. The Company develops, manufactures and markets medical devices. Our revenues arise from the sale of consoles, delivery devices, consumables, service, and support activities.

Revenue information shown by geographic region, based on the sales destination, is as follows:


	Three Months Ended				Six Months Ended
	June 30, 2018		July 1, 2017		June 30, 2018		July 1, 2017
United States	$	5,114	$	5,882	$	9,974	$	11,586
Europe		2,226		1,840		4,660		3,775
Rest of Americas		656		555		1,308		1,164
Asia/Pacific Rim		2,308		1,725		3,871		3,960
	$	10,304	$	10,002	$	19,813	$	20,485

Revenues are attributed to countries based on location of end customers.

No individual country accounted for more than 10% of the Company’s revenues, other than the United States. United States accounted for 49.6% and 58.8% of revenues for the three month periods ended June 30, 2018 and July 1, 2017, respectively. For the six month period ended June 30, 2018 and July 1, 2017, the United States accounted for 50.3% and 56.6% of sales, respectively. International sales, other than the United States, accounted for 50.4% and 41.2% of revenues for the three month periods ended June 30, 2018 and July 1, 2017, respectively. For the six month period ended June 30, 2018 and July 1, 2017, International sales, other than the United States, accounted for 49.7% and 43.4% of sales, respectively.

No customer accounted for more than 10% of total revenues for the three month periods ended June 30, 2018 or July 1, 2017.

No customer accounted for more than 10% of accounts receivable balance as of June 30, 2018 or July 1, 2017.